Stockscreener 앱 받기
10.07
0.20%
0.02
시간 외 거래:
10.08
0.010
+0.10%
전일 마감가:
$10.05
열려 있는:
$10.0799
하루 거래량:
1,760
Relative Volume:
0.01
시가총액:
$641.46M
수익:
-
순이익/손실:
$8.58M
주가수익비율:
75.15
EPS:
0.134
순현금흐름:
$-1.11M
1주 성능:
-0.20%
1개월 성능:
+0.10%
6개월 성능:
+1.72%
1년 성능:
+0.00%
1일 변동 폭
$10.07
$10.08
1주일 범위
$10.05
$10.10
52주 변동 폭
$9.87
$10.10
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
명칭
Drugs Made In America Acquisition Ii Corp
전화
954-870-3104
주소
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, CCXI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.07 | 640.19M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
15.63 | 4.77B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.31 | 1.85B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
19.23 | 912.86M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
16.40 | 772.00M | 0 | 0 | 0 | 0.0647 |
Drugs Made In America Acquisition Ii Corp 주식(DMII)의 최신 뉴스
DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Price to earnings forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView
Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition Ii Corp (DMII) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.10%
자본화:
|
볼륨(24시간):